市場調査レポート
商品コード
1417248
前立腺がん市場レポート:2030年までの動向、予測、競合分析Prostate Cancer Market Report: Trends, Forecast and Competitive Analysis to 2030 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
前立腺がん市場レポート:2030年までの動向、予測、競合分析 |
出版日: 2024年01月29日
発行: Lucintel
ページ情報: 英文 150 - page report
納期: 3営業日
|
前立腺がんの動向と予測
世界の前立腺がん市場は、2024年から2030年までのCAGRが8.7%で、2030年までに推定194億7,000万米ドルに達すると予想されています。この市場の主な促進要因は、前立腺がんの発生率の増加により高度な前立腺治療の必要性が高まっていること、前立腺がん治療薬が第III相臨床試験を経て進歩していること、研究開発と治療技術の進歩のための資金の強化です。世界の前立腺がん市場の将来は、病院薬局、ドラッグストアおよび小売薬局、オンライン薬局市場にチャンスがあり、有望に見えます。
前立腺がん市場に関する洞察
Lucintelは、AR標的療法が予測期間中に最も高い成長を遂げると予想しています。
アジア太平洋地域は、前立腺がんの有病率の増加、いくつかの治療選択肢の利用可能性、技術開発、カスタマイズされた医薬品、および手頃な価格の治療により、予測期間中に最高の成長を遂げると予想されています。
Q.1前立腺がんの市場規模はどれくらいですか:
A1.世界の前立腺がん市場は、2030年までに推定194億7,000万米ドルに達すると予想されています。
Q.2前立腺がん市場の成長予測は何ですか:
A2.世界の前立腺がん市場は、2024年から2030年にかけて8.7%のCAGRで成長すると予想されています。
Q.3前立腺がん市場の成長に影響を与える主な要因は何ですか:
A3.この市場の主な促進要因は、前立腺がんの発生率の増加により高度な前立腺治療の必要性が高まっていること、前立腺がん治療薬が第III相臨床試験を経て進歩していること、研究開発と治療技術の進歩のための資金の強化です。
Q4.市場の主要セグメントは:
A4.前立腺がん市場の将来は、病院薬局、ドラッグストアおよび小売薬局、オンライン薬局市場にチャンスがあり、有望に見えます。
Q5.市場の主要企業は:
A5.前立腺がん関連の主要企業は以下のとおりです。
Q6.今後、最大となる市場セグメントは:
A6.Lucintelは、AR標的療法が予測期間中に最も高い成長を遂げると予想しています。
Q7.市場において、今後5年間に最大になると予想される地域は:
A7.アジア太平洋地域は、前立腺がんの有病率の増加、いくつかの治療選択肢の利用可能性、技術開発、カスタマイズされた薬剤、および手頃な価格の治療法により、予測期間中に最高の成長を遂げると予想されています。
Q8.レポートのカスタマイズは可能か:
A8.はい、Lucintelは追加費用なしで10%のカスタマイズを提供します。
Prostate Cancer Trends and Forecast
The future of the global prostate cancer market looks promising with opportunities in the hospital pharmacies, drug store & retail pharmacies, and online pharmacies markets. The global prostate cancer market is expected to reach an estimated $19.47 billion by 2030 with a CAGR of 8.7% from 2024 to 2030. The major drivers for this market are growing incidence of prostate cancer driving the need for advanced prostate treatments, prostate cancer medications advancing through phase III clinical trials, and enhancing funding for research & development and advancements in treatment technology.
A more than 150-page report is developed to help in your business decisions.
Prostate Cancer by Segment
The study includes a forecast for the global prostate cancer by drug class, distribution channel, and region.
List of Prostate Cancer Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies prostate cancer companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the prostate cancer companies profiled in this report include-
Prostate Cancer Market Insights
Lucintel forecasts that AR-directed therapies is expected to witness highest growth over the forecast period.
APAC is expected to witness highest growth over the forecast period due to The increasing prevalence of prostate cancer, the availability of several treatment choices, technical developments, customized medications, and affordable therapy.
Features of the Global Prostate Cancer Market
Market Size Estimates: Prostate cancer market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Prostate cancer market size by drug class, distribution channel, and region in terms of value ($B).
Regional Analysis: Prostate cancer market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different drug class, distribution channel, and regions for the prostate cancer market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the prostate cancer market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
FAQ
Q.1 What is the prostate cancer market size?
Answer: The global prostate cancer market is expected to reach an estimated $19.47 billion by 2030.
Q.2 What is the growth forecast for prostate cancer market?
Answer: The global prostate cancer market is expected to grow with a CAGR of 8.7% from 2024 to 2030.
Q.3 What are the major drivers influencing the growth of the prostate cancer market?
Answer: The major drivers for this market are growing incidence of prostate cancer driving the need for advanced prostate treatments, prostate cancer medications advancing through phase III clinical trials, and enhancing funding for research & development and advancements in treatment technology.
Q4. What are the major segments for prostate cancer market?
Answer: The future of the prostate cancer market looks promising with opportunities in the hospital pharmacies, drug store & retail pharmacies, and online pharmacies markets.
Q5. Who are the key prostate cancer market companies?
Answer: Some of the key prostate cancer companies are as follows.
Q6. Which prostate cancer market segment will be the largest in future?
Answer: Lucintel forecasts that ar-directed therapies is expected to witness highest growth over the forecast period.
Q7. In prostate cancer market, which region is expected to be the largest in next 5 years?
Answer: APAC is expected to witness highest growth over the forecast period due to The increasing prevalence of prostate cancer, the availability of several treatment choices, technical developments, customized medications, and affordable therapy
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.